ALKERMES | ALKS - Mitarbeiter Gesamtzahl





Mitarbeiter Veränderung Datum
AbbVie 55K 5K 2024-12
Acadia Pharmaceuticals 653 56 2024-12
ALKERMES 1.8K 300 2024-12
Amgen 28K 1.3K 2024-12
Biogen 7.6K 35 2024-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Bristol-Myers Squibb 34.1K 0 2024-12
Coherus Biosciences 306 53 2023-12
Eli Lilly 47K 4K 2024-12
Gilead Sciences 17.6K 400 2024-12
Heron Therapeutics 126 77 2023-12
Ionis Pharmaceuticals 1.07K 142 2024-12
J&J 138.1K 6.2K 2024-12
Malin Corporation 5 1 2022-12
Merck 75K 3K 2024-12
Minerva Neurosciences 9 0 2023-12
Nektar Therapeutics 137 79 2023-12
Neurocrine Biosciences 1.8K 400 2024-12
Otsuka Holdings 35.34K 950 2024-12
Pfizer 81K 7K 2024-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Vertex Pharmaceuticals 6.1K 700 2024-12